CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01093 CSPC PHARMA

Pre-opening 10-15 09:19:37

8.685

-0.125

-1.42%

High8.685	Low8.685	Vol5.84M
Open8.685	D1 Closing8.810	Amplitude0.00%
Mkt Cap100.07B	Tradable Cap100.07B	Total Shares11.52B
T/O51.48M	T/O Rate0.05%	Tradable Shares11.52B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01093","market":"HK","secType":"STK","nameCN":"CSPC PHARMA","latestPrice":8.685,"timestamp":1792027144478,"preClose":8.81,"halted":0,"volume":5838000,"delay":0,"changeRate":-0.014188422247446084,"floatShares":11522000000,"shares":11522000000,"eps":0.39850610835582906,"marketStatus":"Pre-opening","change":-0.125,"latestTime":"10-15 09:19:37","open":8.685,"high":8.685,"low":8.685,"amount":51482175.800000004,"amplitude":0,"askPrice":8.685,"askSize":90000,"bidPrice":8.685,"bidSize":98000,"shortable":3,"etf":0,"ttmEps":0.762899953104401,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":1,"adr":0,"listingDate":772128000000,"exchange":"SEHK","adjPreClose":8.81,"dividendRate":0.033402,"openAndCloseTimeList":[[1792027800000,1792036800000],[1792040400000,1792051200000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"CSP.HK","impliedVol":0.4612,"impliedVolPercentile":0.1626},"requestUrl":"/m/hq/s/01093/wiki","defaultTab":"wiki","newsList":[{"id":"1180968117","title":"Movement Alert｜CSPC PHARMA Falls 3.09% in Regular Trading, Recent R&D Updates Fail to Prevent Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1180968117","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180968117?lang=en_us&edition=fundamental","pubTime":"2026-10-14 13:42","pubTimestamp":1791956540,"startTime":"0","endTime":"0","summary":"On October 14, CSPC PHARMA fell 3.09% in Regular Trading, trading at HK$8.785, with turnover of HK$255 million.The most recent company-specific developments were R&D related. Earlier this month, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CSPC Pharma Slips as SYS6002 Cervical Cancer Data Fails to Lift","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172244367","title":"Movement Alert｜CSPC PHARMA Falls 3.07% in Regular Trading, Innovative Drug Sector Retreats After Holiday","url":"https://stock-news.laohu8.com/highlight/detail?id=1172244367","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172244367?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:41","pubTimestamp":1791510085,"startTime":"0","endTime":"0","summary":"On October 9, CSPC PHARMA fell 3.07% in regular trading, trading at 9.0 Hong Kong dollars, with Turnover of 2.75 billion Hong Kong dollars.On the news front, the innovative drug sector faced broad...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CSPC Pharma Drops as Furmonertinib Trial Miss Clouds Sector","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673907195","title":"CSPC Pharma Presents Data from Cervical Cancer Study at Gynecologic Cancer Society Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2673907195","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673907195?lang=en_us&edition=fundamental","pubTime":"2026-10-08 19:30","pubTimestamp":1791459000,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  presented data from a phase I clinical study of SYS6002 as a rapid oral presentation at the 2026 Annual Global Meeting of the International Gynecologic Cancer Society.The trial testing the drug as monotherapy for the treatment of advanced cervical cancer found it to have a manageable safety profile and preliminary efficacy, a Thursday bourse filing showed.The drug is currently being studied for the treatment of advanced cervical cancer previously treated with immunotherapy in a phase III trial.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0315179316.USD","LU0326950275.SGD","IE00B031HY20.USD","LU1152091754.HKD","LU0501845795.SGD","IE00BZ08YS42.EUR","LU0140636845.USD","LU0067412154.USD","HK0000165453.HKD","LU1993786604.SGD","IE0008369823.USD","LU1328277881.USD","01093","LU1226287792.SGD","BK1191","LU1152091168.USD","LU1226287875.USD","LU1813983027.USD","IE00BZ08YR35.GBP","BK1521","LU1951186391.HKD","KURE","IE00BZ08YT58.USD","LU0072913022.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","BK1515","LU2039709279.SGD","LU1960683339.HKD","LU1226287529.USD","LU1807302812.USD","LU1008478684.HKD","SG9999004220.SGD","IE00B543WZ88.USD","LU0880133367.SGD","LU1226288253.USD","LU1226288170.HKD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165903998","title":"CSPC Pharma Unveils Phase I Data for SYS6002 Monotherapy in Advanced Cervical Cancer at IGCS 2026 Rapid Oral Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1165903998","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165903998?lang=en_us&edition=fundamental","pubTime":"2026-10-08 18:28","pubTimestamp":1791455310,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the company presented Phase I clinical trial data for SYS6002 monotherapy in the treatment of advanced cervical cancer as a rapid oral presentation at the 2026...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1152091168.USD","LU0072913022.USD","LU0314109678.HKD","IE0008368742.USD","IE00B5MMRT66.SGD","LU0501845795.SGD","LU1152091754.HKD","LU1951186391.HKD","LU1993786604.SGD","BK1191","IE00B031HY20.USD","LU2039709279.SGD","LU0067412154.USD","LU0315179316.USD","LU0326950275.SGD","BK1515","SG9999004220.SGD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1960683339.HKD","LU1226288170.HKD","LU1813983027.USD","LU1008478684.HKD","LU0140636845.USD","01093","LU1226288253.USD","IE0008369823.USD","LU1807302812.USD","IE00BZ08YS42.EUR","LU1226287529.USD","LU1226287792.SGD","KURE","LU1328277881.USD","BK1521","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022424","title":"CSPC Pharmaceutical Group Stock Sheds 5.4% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022424?lang=en_us&edition=fundamental","pubTime":"2026-10-08 16:31","pubTimestamp":1791448260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 5.4% to 9.29 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.4% to 23785.79.This was the stock's second consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 15% short of its 52-week high of HK$10.96, which the company reached Jan. 30.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 3.3%, SSY Group Ltd. rose 1.3%, and United Laboratories International Holdings Ltd. fell 1.3%.Trading volume totaled 92.2 million shares, compared to the 50-day average of 90.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","LU0326950275.SGD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU0067412154.USD","LU1993786604.SGD","IE00B5MMRT66.SGD","91335","IE00B543WZ88.USD","LU1152091754.HKD","LU1008478684.HKD","LU0072913022.USD","LU0501845795.SGD","BK1515","LU1328277881.USD","LU1226287529.USD","01093","LU1807302812.USD","SG9999004220.SGD","LU0140636845.USD","IE00BZ08YT58.USD","LU0880133367.SGD","LU1152091168.USD","LU1226287792.SGD","KURE","LU1226287875.USD","HK0000165453.HKD","BK1521","LU1960683339.HKD","LU2039709279.SGD","LU0314109678.HKD","BK1191","LU1813983027.USD","LU1226288253.USD","LU0315179316.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU1951186391.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113451181","title":"Movement Alert｜CSPC PHARMA Falls 3.01% in Regular Trading, Innovative Drug Sector Pullback Ahead of ESMO Data Readout","url":"https://stock-news.laohu8.com/highlight/detail?id=1113451181","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113451181?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:01","pubTimestamp":1791435719,"startTime":"0","endTime":"0","summary":"On October 8, CSPC PHARMA fell 3.01% in regular trading, trading at 9.52 Hong Kong dollars with turnover of 376 million Hong Kong dollars. The decline came as the broader innovative drug sector...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CSPC Pharma Falls Ahead of ESMO Oncology Data Readout","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673703224","title":"CSPC Pharmaceutical Group Stock Rises 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673703224","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673703224?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:32","pubTimestamp":1791275520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rallied 1.5% to 10.00 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 24280.56.The stock's rise snapped a two-day losing streak.CSPC Pharmaceutical Group Ltd. closed 8.8% below its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 4.3%, SSY Group Ltd. rose 1.8%, and United Laboratories International Holdings Ltd. rose 1.5%.Trading volume totaled 36.5 million shares, compared to the 50-day average of 92.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1813983027.USD","LU0501845795.SGD","LU0072913022.USD","01093","LU0140636845.USD","LU1960683339.HKD","LU1951186391.HKD","LU1008478684.HKD","BK1515","IE00BZ08YR35.GBP","LU1226287875.USD","IE00BZ08YT58.USD","LU1226287529.USD","KURE","LU1328277881.USD","IE00B543WZ88.USD","LU1226288170.HKD","LU0067412154.USD","HK0000165453.HKD","LU1152091168.USD","LU1993786604.SGD","IE00B031HY20.USD","LU0314109678.HKD","LU0880133367.SGD","IE0008368742.USD","LU1807302812.USD","LU1152091754.HKD","BK1521","BK1191","IE0008369823.USD","IE00B5MMRT66.SGD","91335","LU0315179316.USD","SG9999004220.SGD","LU1226288253.USD","LU1226287792.SGD","IE00BZ08YS42.EUR","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673020702","title":"CSPC Pharma to Present Updates from Eight Trials at European Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2673020702","media":"MT Newswires Live","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673020702?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:16","pubTimestamp":1791202608,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  will present the latest updates from eight clinical trials at the European Society for Medical Oncology  Congress, two of which have been selected as late-breaking abstracts.The updates will be presented at the conference, to be held in Madrid, Spain, from Oct. 23 to Oct. 27, as one proffered paper, three rapid oral, three poster, and one e-poster presentation, a Monday bourse filing showed.The updates will cover a broad range of oncology types such as breast, lung, gastric, liver, colorectal, and pancreatic cancers.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KURE","IE00BZ08YR35.GBP","LU1993786604.SGD","LU1807302812.USD","SG9999004220.SGD","IE00B031HY20.USD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU0072913022.USD","LU0315179316.USD","IE0008369823.USD","LU1951186391.HKD","IE0008368742.USD","01093","BK1521","LU1226287529.USD","LU0501845795.SGD","LU1328277881.USD","LU1152091754.HKD","BK1191","IE00B5MMRT66.SGD","EPV","LU1226287875.USD","LU1960683339.HKD","LU2039709279.SGD","LU1226288170.HKD","LU1226288253.USD","LU1813983027.USD","BK1515","LU0880133367.SGD","LU0326950275.SGD","LU1008478684.HKD","LU1152091168.USD","LU0067412154.USD","HK0000165453.HKD","LU1226287792.SGD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1139198272","title":"CSPC Pharma to Present Eight Oncology Trial Updates, Including Two Late-Breaking Abstracts, at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1139198272","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139198272?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198229,"startTime":"0","endTime":"0","summary":"Hong Kong-based CSPC Pharmaceutical Group Limited (CSPC Pharma) announced it will disclose data from eight oncology clinical trials at the European Society for Medical Oncology (ESMO) Congress in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170526775","title":"CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1170526775","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170526775?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198018,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the group will present 8 latest clinical trial advances at the European Society for Medical Oncology (ESMO) Annual Congress, taking place in Madrid, Spain from...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","BK1521","LU1008478684.HKD","LU1960683339.HKD","LU1226287529.USD","BK1515","01093","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU0072913022.USD","LU2039709279.SGD","HK0000165453.HKD","LU0315179316.USD","IBBQ","LU0067412154.USD","LU0880133367.SGD","IE00BZ08YT58.USD","LU0326950275.SGD","IE0008368742.USD","IE00B031HY20.USD","LU0314109678.HKD","IE00B543WZ88.USD","LU1328277881.USD","LU1152091168.USD","LU1807302812.USD","LU1226287792.SGD","SG9999004220.SGD","LU1226287875.USD","LU1993786604.SGD","PSYK","BMED","IE0008369823.USD","BK1191","LU1813983027.USD","IE00BZ08YR35.GBP","LU1226288253.USD","IBBJ","LU0501845795.SGD","LU0140636845.USD","LU1152091754.HKD","KURE","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100732210","title":"CSPC PHARMA Maintains 11.52 Billion Shares Outstanding in September; 1.15 Billion Options Could Add 10% Dilution","url":"https://stock-news.laohu8.com/highlight/detail?id=1100732210","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100732210?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:43","pubTimestamp":1790937787,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (CSPC PHARMA) filed its Monthly Return for Equity Issuer to the Hong Kong Stock Exchange for the period ended 30 September 2026, confirming a stable capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","LU0106261372.USD","ELIL","09995","BK4592","IE00B5MMRT66.SGD","LU0354030438.USD","LU2602419157.SGD","LU0289961442.SGD","IE00B3PB1722.GBP","WDNA","LU0792757196.USD","LU1162221912.USD","BK5011","LU0353189680.USD","LU0006306889.USD","LU1989771016.USD","LU2491049909.HKD","THNR","600276","LU0130102774.USD","LU0661504455.SGD","LU1019632923.USD","LU1929549753.HKD","LU2539964713.USD","LU1974910355.USD","LU1093756325.SGD","SG9999014914.USD","LU0920783379.SGD","LU2211815571.USD","688331","IE00BGHQF631.EUR","SG9999002232.USD","IE00BVYPNV92.GBP","RXL","LU0348735423.USD","LU0321505439.SGD","IE0002270589.USD","LU1267930730.SGD","LU0348784397.USD","IE00B7KXQ091.USD","LU0971552673.USD","IE00BKDWB100.SGD","LU2476274308.USD","BMY","IE00B3M56506.USD","LU0225283273.USD","KURE","LU2265009873.SGD","IE000BZT7R73.USD","XLV","LU2399975544.HKD","LU1732800096.USD","LU0210536198.USD","LU2091194634.USD","LU0211327993.USD","AZN.UK","LU2746668461.USD","LU0477156953.USD","IE0005OL40V9.USD","LU0857590862.USD","LU2750360997.AUD","LU2087625088.SGD","LU1309081286.SGD","NVO","LU2471134879.HKD","BK0028","00013","LU1037948541.HKD","LU0980610538.SGD","LU1880407132.USD","LU0326950275.SGD","IE00BK4W5L77.USD","03165","LU1997245094.SGD","LU0158827781.USD","LU1571399168.USD","LU2361044865.SGD","NVOC","LU1267930490.SGD","LU2580892789.USD","LU0011850046.USD","LU0289739343.SGD","IE00B19Z3B42.SGD","BK1515","LU0784385840.USD","IE00BKVL7J92.USD","LU1170363599.USD","BK4581","LU0795875169.SGD","LU2168564495.EUR","BK4534","LU1066051498.USD","LU2462591350.SGD","LU2111349929.HKD","LU0067412154.USD","LU1580142542.USD","LU1366192091.USD","LU1328615791.USD","LU0154236417.USD","SG9999014880.SGD","LU0158827948.USD","688506","LU0096364046.USD","LU0170899867.USD","LU1670711040.USD","LU0405327494.USD","RHHBY","LU0823416689.USD","IE00BN8TJ469.HKD","LU2778985437.USD","IE0034235188.USD","LU1814569148.SGD","LU0672654240.SGD","LU0976567544.SGD","LU0738911758.USD","SG9999004220.SGD","LU0203347892.USD","LU1400636491.USD","BK1521","LU2097828714.EUR","LU1355424745.HKD","LU0070302665.USD","GB00BDT5M118.USD","LU1301847155.USD","LU0405327148.USD","LU0417517546.SGD","IE00B1XK9C88.USD","IE0008369823.USD","BK1587","IE00B4R5TH58.HKD","IE00B19Z3581.USD","OZEM","IE00BZ1G4Q59.USD","LU1670756490.USD","IE00BQJZX424.USD","BK4007","LU0987226296.USD","LU0784383803.USD","LU1794554557.SGD","LU2114397693.USD","BK1191","LU2023250504.SGD","LU1061106388.HKD","LU0203201768.USD","LU1323610961.USD","LU0466842654.USD","IBBQ","LU2750360641.GBP","03933","LU0957799991.USD","IE000WAW04H5.SGD","LU1934455863.HKD","IE00BJT1NW94.SGD","LU0225771236.USD","LU0238689110.USD","02096","IBB","LU0463099449.HKD","LU1894683348.USD","LU2488822045.USD","HCM","LU2129689605.HKD","HK0000165453.HKD","LU1863844749.USD","LU0820562030.AUD","LU0320765059.SGD","LU0124676726.USD","LU0161305163.EUR","LU0965509283.SGD","BK0183","LU1066051811.HKD","LU0787776722.HKD","LU2168564149.EUR","LU0320765489.SGD","LU1623119135.USD","LU1917777945.USD","LU0133085943.USD","LU1880407215.USD","LU2242646821.SGD","LU0985481810.HKD","LU1923622614.USD","SGXZ81514606.USD","LU1993786604.SGD","LU1236620834.HKD","LU1670710661.SGD","LU0203202063.USD","LU1960683339.HKD","IE0002141913.USD","LU0256863811.USD","LU0072461881.USD","LU1035773651.USD","LU0345770308.USD","LU0211326839.USD","LU0997586432.USD","LU1064130708.USD","LU0949170426.SGD","LU0306807586.USD","LU0964806797.USD","LU0943347566.SGD","LU2063271972.USD","LU0575583348.USD","LU2168563687.JPY","LU0861579265.USD","LU1202635105.USD","LU1051770623.HKD","LU2756315664.SGD","IE00B42XCP33.USD","IE00B543WZ88.USD","LU0047473722.SGD","LU0972486137.USD","LU2433249047.HKD","PAWZ","MHIP","LU0316494557.USD","LU2746668974.SGD","SG9999003800.SGD","TBXU","LU0634319403.HKD","LU0640476718.USD","IE00BJLML261.HKD","LU2347655156.SGD","LU0057025933.USD","BK4566","LU0244354667.USD","LU1119994496.HKD","LU1228905037.USD","NVS","BK1593","LU2039709279.SGD","SG9999015952.SGD","LU1820825898.SGD","LU0889565080.SGD","LU1934455277.USD","LU2461242641.AUD","LU0795875086.SGD","LLYX","LU1868837136.USD","IE00BKPKM429.USD","BBH","LU0310799852.SGD","LU0472753341.HKD","LU0471298694.HKD","LU1813983027.USD","LU1829250122.USD","LU0887340254.USD","LU0920840948.USD","LU1280957306.USD","LU0456855351.SGD","IYH","LU0047473722.EUR","IE00B1BXHZ80.USD","LU1145028129.USD","IE00BZ08YT58.USD","LU0058720904.USD","GSK.UK","BMED","LU2242644610.SGD","JDOC","IE00BVYPNW00.USD","IE00BJJMRY28.SGD","LU0880133367.SGD","SG9999013999.USD","LU0314109678.HKD","LU2089283258.USD","LU0130517989.USD","LU0960981461.USD","LU2491050071.SGD","LU2237443382.USD","LU2293690082.USD","LU0211331839.USD","IE000M9KFDE8.USD","LU0786609619.USD","LU0128525689.USD","LU0827474353.SGD","SGXZ51526630.SGD","LU1487256676.USD","BK4585","LU0052756011.USD","LU2237443978.SGD","LU2462157665.USD","LU2360106947.USD","LU2552382215.SGD","LU0499090636.EUR","SG9999015978.USD","LU0072913022.USD","LU0289739699.SGD","TRUH","LU1244550221.USD","LU2237443895.HKD","LU2133065610.SGD","LU2357627491.SGD","LU2097828631.EUR","LU2237443622.USD","CANC","LU0784384876.USD","LU1655091616.SGD","LU1988902786.USD","IE00BLSP4452.SGD","LU2279689827.SGD","SG9999014575.USD","LU1273509221.SGD","LU2360032135.SGD","BNTX","LU2168564222.USD","LU1496350502.SGD","IXJ","LU0162691827.USD","LU1188198961.HKD","LU0432979614.USD","LU2125909593.SGD","LU0211326755.USD","LU1645745479.HKD","SG9999014567.USD","LU1066051225.USD","LU2552382058.USD","LU0171293334.USD","LU1069344957.HKD","LU1244550494.USD","LU1670711123.USD","BK4588","LU2468319806.SGD","01093","LU0502904849.HKD","LU2023250843.SGD","LU0501845795.SGD","IE00BWXC8680.SGD","LU2023251221.USD","LU2108987350.USD","LU0823399737.USD","LU0882574139.USD","LU0561508036.HKD","LU2361045086.USD","BK0196","LU2125909247.SGD","IE00BZ08YR35.GBP","BK0188","BK1161","LU0963555726.SGD","LU2237443549.SGD","LU0198837287.USD","SGXZ31699556.SGD","LU0965509101.SGD","LU0640478417.SGD","LU1400636574.HKD","SGXZ57979304.SGD","BK4550","LU2552382132.HKD","LU1831875114.USD","IE00BKPKM643.USD","LU0109981661.USD","LU2289578879.USD","IE00B031HY20.USD","LU1008478684.HKD","LU1548497426.USD","LU2362541273.HKD","LU2097828474.EUR","LU1551013425.SGD","LU2596442595.SGD","IE00BN29S564.USD","IE00BFSS7M15.SGD","LU2097828557.USD","IE00B3T34201.USD","LU0708995401.HKD","SG9999017495.SGD","LU1093756168.USD","LU1146622755.USD","SMMT","LU1983299246.USD","LU2347655073.USD","ELIS","LU0353189763.USD","LU0971552830.HKD","LU0097036916.USD","LU0390134368.USD","BK4516","LU2357305700.SGD","IE00BJJMRZ35.SGD","LU0496365809.HKD","GDOC","LU0256863902.USD","SG9999014898.SGD","IE00B4JS1V06.HKD","LU0310800379.SGD","LU1255011170.USD","LU1934455194.USD","BK1583","LU1781817850.SGD","LU1226288253.USD","LU0237698245.USD","LU1127390331.HKD","BK4535","LU0912757837.SGD","LU1883839398.USD","IE0009355771.USD","LU0820561909.HKD","LU0211328371.USD","LU1670627923.USD","LU2087621335.USD","HRTS","SG9999018865.SGD","LU3187612489.SGD","09926","IE00BSNM7G36.USD","LU1670710588.SGD","LU0265550359.USD","LU2125154778.USD","VHT","LU1551013342.USD","LU1069347547.HKD","LU1691799644.USD","LU1969619763.USD","LU1302929846.USD","LU0267386448.USD","LU0345770993.USD","LU0683600562.USD","SG9999014906.USD","LU2456880835.USD","SG9999001176.SGD","LU1153585028.USD","LU0540923850.HKD","LU1152091754.HKD","LU2355687059.USD","LU0726765562.USD","LU0174119429.USD","LU1064927863.SGD","NVOH","LU2361044949.HKD","IE0008368742.USD","LU1152091168.USD","LU0417516571.SGD","LU1430594728.SGD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU2896262040.SGD","LU0265550946.USD","SG9999014542.SGD","LU1046248800.SGD","LU2271345857.HKD","LU0648001328.SGD","ILDR","BK4533","LU0109394709.USD","LU0823434583.USD","IE00B775H168.HKD","IE0004445015.USD","LU1291159041.SGD","LU1894683264.USD","LU1807302812.USD","LU0455707207.USD","TMED","LU2129689514.USD","LU2471134523.USD","LLYZ","LU2646069778.SGD","LU1267930227.SGD","LU1064131342.USD","BK1589","LU1585245621.USD","LU1023059063.AUD","LU2236285917.USD","LU1481599808.USD","IE0000B7K699.USD","LU1228905540.USD","LU0310800965.SGD","IHE","SG9999015341.SGD","BK0060","LU0122379950.USD","LU1244550577.SGD","IE0004445239.USD","BK1588","LU1979441026.SGD","LU1074936037.SGD","LU2089284900.SGD","LU2362541513.USD","LU1718418525.SGD","AGNG","IE0001KFT4U8.USD","LU1003077747.HKD","REGN","BK4568","LU1046234339.USD","LU1961090484.USD","LU0321505868.SGD","LU0607220059.USD","LU2097828805.USD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU1201861249.SGD","GLAM","LU2028103732.USD","LU2129689431.USD","BK4532","IE000SO60NU8.SGD","LLY","LU1057294990.SGD","LU0069063385.USD","LU1098665638.USD","IE00BJJMRX11.SGD","LU0171276677.USD","LU0140636845.USD","LU1989772923.USD","MRK","LU2089984988.USD","LU0079474960.USD","LU1226288170.HKD","LU1629891620.HKD","LU0348825331.USD","LU0345777147.USD","LU1037948897.HKD","LU1226287792.SGD","LU0348766576.USD","LU2213496289.HKD","SG9999001176.USD","PFE","LU1196032939.SGD","LU2476274720.SGD","LU2148510915.USD","LU2756315318.SGD","LU0708994859.HKD","LU2023250330.USD","LU0868494617.USD","BK4548","SG9999014559.SGD","LU2491050154.USD","LU1699723380.USD","LU1868836914.USD","IE00BDGV0183.EUR","LU0234570918.USD","LU1261432733.SGD","SGXZ99366536.SGD","03692","IE00BWDBJ516.SGD","LU0029864427.USD","LU0985320562.USD","LU1226287875.USD","LU0545562505.USD","LU0511384066.AUD","LU0949170772.SGD","SG9999015358.SGD","LU2106854487.HKD","LU0320765992.SGD","LU0315179316.USD","SG9999015986.USD","BK4139","LU2168564065.EUR","LU0820561818.USD","FHLC","IE00B2B36J28.USD","IE00BK4W5M84.HKD","LU1481600234.SGD","LU2328871848.SGD","LU2495084118.USD","LU0889565916.HKD","LU2471134952.CNY","LU0889566641.SGD","BK4551","LU0323591593.USD","LU0965509010.AUD","LU1720051108.HKD","LU0526926950.USD","LU1035777561.USD","LU0964807845.USD","LU0149534421.HKD","LU0094547139.USD","LU0203345920.USD","ABBV","LU1941712264.USD","LU1032466523.USD","IE00BFXG1179.USD","LU0128525929.USD","BK4578","LU0348767384.USD","SG9999001440.SGD","LU0077335932.USD","MEDI","LU1015430645.USD","LU2362540622.SGD","LU0417516902.SGD","IE000MB6IJN5.SGD","LU1496350171.SGD","LU0868494708.USD","LU1236620750.USD","LU0757432116.USD","LU0109391861.USD","LU1226287529.USD","LU0348783233.USD","NVOX","PPH","LU1863844665.USD","LU0553294199.USD","IE00BBT3K403.USD","BK0239","LU1941712348.USD","LU0345777659.USD","LU0965508806.USD","LU0997586515.USD","LU0053666078.USD","LU2580892862.HKD","LU0320765646.SGD","LU1064131003.USD","LU1153584641.USD","BK1574","LU0689472784.USD","LU0061475181.USD","LU1670628061.USD","MEDX","LU1104425308.USD","LU1989772840.SGD","LU2324357040.USD","LU1116320901.HKD","BK0012","BK4559","IE0034235071.USD","LU1035775433.USD","LU0234572021.USD","LU1804176565.USD","LU0385154629.USD","01801","LU2471134796.USD","LU2417539215.USD","LU1084165304.USD","LU2237443465.HKD","LU1839511570.USD","LU1868836757.USD","LU1997244956.HKD","LU0859254822.USD","LU1868836591.USD","LU1066053197.SGD","BK4599","IE00BFSS8Q28.SGD","FTXH","LU1078025761.USD","LU1720051017.SGD","SG9999011175.SGD","CURE","LU0208291251.USD","LU0882574055.USD","LU0395794307.EUR","LU1997245177.USD","LU0969580561.USD","LU1267930573.SGD","IE00BPRC5H50.USD","LU0417516738.SGD","LU1328277881.USD","LU2293690249.USD","01530","LU0306806265.USD","LU0348827113.USD","IE00BLSP4239.USD","LU0557290698.USD","LU2242652126.USD","LU0689626769.HKD","SG9999018857.SGD","LU0471298777.SGD","LU2237438978.USD","SG9999002224.SGD","LU1003076772.USD","IE000F7OJYX1.SGD","PJP","LU2264538146.SGD","LU1712237335.SGD","LU0114720955.EUR","LU0098860793.USD","LU2112291526.USD","LU1732799900.SGD","LU0225284248.USD","LU1400636657.SGD","LU0942090050.USD","LU0266013472.USD","LU0354030511.USD","LU1232071149.USD","SG9999015945.SGD","LLII","LU1116320737.USD","LU0823434740.USD","LU1019634622.SGD","LU0784385170.HKD","LU1267930813.SGD","01276","LU2125154935.USD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199042124","title":"Movement Alert｜CSPC PHARMA Falls 3.13% in Regular Trading, Trading at HK$9.735","url":"https://stock-news.laohu8.com/highlight/detail?id=1199042124","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199042124?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:47","pubTimestamp":1790905679,"startTime":"0","endTime":"0","summary":"On October 2, CSPC PHARMA fell 3.13% in regular trading, trading at HK$9.735 per share, with turnover of HK$68.23 million.Within the Pharmaceuticals sector where CSPC PHARMA belongs, the overall...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672577917","title":"CSPC Pharmaceutical Group (SEHK:1093) Could Be 26% Undervalued Following Three Phase III Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2672577917","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672577917?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:26","pubTimestamp":1790853967,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (SEHK:1093) has just packed three late stage pipeline updates into one week, covering diabetes, lung cancer and breast cancer therapies and giving investors fresh clinical data to weigh.\nThe TG103, JMT101 and HB1801 updates have landed against a backdrop of building momentum in CSPC Pharmaceutical Group’s shares, with a 1-day share price return of 6.28%, a 90-day share price return of 33.38% and a 3-year total shareholder return of 109.87%. This suggests traders are...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/cspc-pharmaceutical-group-sehk1093-could-be-26-undervalued-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/cspc-pharmaceutical-group-sehk1093-could-be-26-undervalued-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1152091754.HKD","LU1807302812.USD","01093","IE00BZ08YS42.EUR","LU1008478684.HKD","IE00B543WZ88.USD","LU1960683339.HKD","IE00BZ08YT58.USD","LU0880133367.SGD","LU2039709279.SGD","LU1226287875.USD","LU1328277881.USD","LU1813983027.USD","LU1951186391.HKD","BK1521","BK1515","DCF","LU1152091168.USD","KURE","SG9999004220.SGD","LU1226288253.USD","LU0067412154.USD","BK1191","LU0072913022.USD","IE0008368742.USD","LU0140636845.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","HK0000165453.HKD","LU0501845795.SGD","LU0315179316.USD","LU0314109678.HKD","LU1226288170.HKD","LU1993786604.SGD","IE00B031HY20.USD","IE0008369823.USD","LU1226287529.USD","LU1226287792.SGD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672272734","title":"CSPC Reports Blood Sugar Reduction in Phase III Diabetes Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672272734","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672272734?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:31","pubTimestamp":1790832718,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  reported blood sugar reductions of up to 1.38 percentage points in a Phase III study of its efmedaglutide alfa injection in Chinese adults with type 2 diabetes.At Week 28, the 15-mg dose reduced HbA1c by 1.38 percentage points from baseline and was non-inferior to dulaglutide 1.5 mg, the company said in a Wednesday filing on the Hong Kong Exchange.The reduction was sustained through Week 52, with HbA1c falling 1.31 percentage points versus 1.25 percentage points for dulaglutide.CSPC said the safety profiles were generally similar across the treatment groups, with gastrointestinal events being the most common adverse events. No severe hypoglycemia was reported.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000165453.HKD","LU1807302812.USD","LU0326950275.SGD","LU0880133367.SGD","LU0501845795.SGD","LU1152091168.USD","01093","LU1226288170.HKD","LU1993786604.SGD","LU0314109678.HKD","LU0140636845.USD","IE0008368742.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1226287529.USD","LU1226287792.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU1328277881.USD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1226288253.USD","KURE","IE00BZ08YR35.GBP","LU1960683339.HKD","IE00B543WZ88.USD","LU1951186391.HKD","LU0072913022.USD","LU1152091754.HKD","LU2039709279.SGD","BK1521","IE0008369823.USD","BK1515","BK1191","LU1813983027.USD","SG9999004220.SGD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106957099","title":"CSPC Pharma Announces Positive Phase III Results for Weekly GLP-1 Candidate TG103 in Chinese Type 2 Diabetes Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1106957099","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106957099?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:23","pubTimestamp":1790770997,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (CSPC Pharma) has disclosed favourable Phase III data for Efmedaglutide Alfa Injection (TG103), a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128085196","title":"CSPC Pharmaceutical (01093) Reveals Positive Phase III Results for Edaglutide Alfa Injection Combined with Metformin in Chinese Adults with Type 2 Diabetes at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1128085196","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128085196?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:12","pubTimestamp":1790770347,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group Limited (01093) has announced that the Group presented the positive results of a Phase III clinical study of its glucagon-like peptide-1 (GLP-1) receptor agonist, Edaglutide...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU1807302812.USD","LU0326950275.SGD","LU0880133367.SGD","LU0501845795.SGD","LU1152091168.USD","01093","LU1226288170.HKD","LU1993786604.SGD","LU0314109678.HKD","LU0140636845.USD","IE0008368742.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","LU1226287529.USD","LU1226287792.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU1328277881.USD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1226288253.USD","KURE","IE00BZ08YR35.GBP","LU1960683339.HKD","IE00B543WZ88.USD","LU1951186391.HKD","LU0072913022.USD","LU1152091754.HKD","LU2039709279.SGD","BK1521","IE0008369823.USD","BK1515","BK1191","LU1813983027.USD","SG9999004220.SGD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671274102","title":"CSPC Pharmaceutical Group Stock Rallies 6.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2671274102","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671274102?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:31","pubTimestamp":1790757060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. advanced 6.3% to 10.07 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.4% to 24613.27.This was the stock's third consecutive day of gains.CSPC Pharmaceutical Group Ltd. closed 8.1% short of its 52-week high of HK$10.96, which the company achieved Jan. 30.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. rose 2.9%, SSY Group Ltd. rose 2.0%, and United Laboratories International Holdings Ltd. rose 4.2%.Trading volume totaled 158.1 million shares, compared to the 50-day average of 92.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072913022.USD","BK1521","LU0326950275.SGD","LU1951186391.HKD","SG9999004220.SGD","LU1008478684.HKD","LU1226288253.USD","LU2039709279.SGD","HK0000165453.HKD","IE00BZ08YT58.USD","LU1226287792.SGD","91335","LU1226288170.HKD","IE00BZ08YS42.EUR","LU1813983027.USD","IE00B031HY20.USD","IE00B5MMRT66.SGD","IE0008368742.USD","LU1226287875.USD","LU0315179316.USD","LU1993786604.SGD","LU1960683339.HKD","IE00BZ08YR35.GBP","LU1152091168.USD","LU0501845795.SGD","LU1328277881.USD","IE00B543WZ88.USD","BK1191","IE0008369823.USD","01093","LU1807302812.USD","LU0880133367.SGD","LU0067412154.USD","BK1515","KURE","LU1152091754.HKD","LU0140636845.USD","LU0314109678.HKD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128696299","title":"AI Drug Discovery Sector Heats Up: ChinaAMC Hang Seng Biotech (03069) Rises Over 4% Intraday, ChinaAMC Innovative Drugs (03525) Gains Over 3% in Afternoon Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128696299","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128696299?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:48","pubTimestamp":1790747302,"startTime":"0","endTime":"0","summary":"The AI drug discovery ETF extended its recent rally, with ChinaAMC Hang Seng Biotech (03069) climbing 3.58% to HK$16.8 as of press time, while ChinaAMC Innovative Drugs (03525) rose 2.95% to...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU0359201885.HKD","BK1610","LU0880133367.SGD","01477","LU1226288253.USD","QTOC","LU1023057109.AUD","BK1521","LU0072913022.USD","BK4585","BK1576","LU1008478684.HKD","03069","IE0008369823.USD","LU0359202008.SGD","LU1226287875.USD","LU1807302812.USD","BK1583","LU1226287792.SGD","IE00BZ08YS42.EUR","LU0315179316.USD","HK0000165453.HKD","SG9999004220.SGD","LU0314109678.HKD","LU1226288170.HKD","AGIX","LU0359201612.USD","BK1574","KURE","03525","BK4550","HK0000320264.USD","LU1152091168.USD","LU0501845795.SGD","BK4588","LU1152091754.HKD","LU1960683339.HKD","01093","CHAT","FDN","LU1328277881.USD","HK0000306685.HKD","IE00BZ08YR35.GBP","LU0326950275.SGD","IE00B5MMRT66.SGD","LU0140636845.USD","LU2543165471.USD","HK0000320223.HKD","IE0008368742.USD","LU0067412154.USD","LU1226287529.USD","HK0000306701.USD","LU1951186391.HKD","LU1993786604.SGD","LU2039709279.SGD","BK1515","LU1813983027.USD","01548","ARTY","AIPO","BK1141","01276","BK1191","IE00BZ08YT58.USD","VTHR","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101287526","title":"CSPC Pharma Shares Rise Nearly 6% on String of R&D Updates Spanning mRNA Cancer Vaccines and Recombinant Protein Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1101287526","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101287526?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:30","pubTimestamp":1790735415,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) rose nearly 6%, up 5.86% as of press time to HK$10.03, with turnover of HK$402 million.On the news front, between September 28 and 29, CSPC Pharma disclosed multiple R&D...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","LU0880133367.SGD","KURE","LU1226287529.USD","LU0501845795.SGD","LU0140636845.USD","LU0315179316.USD","LU1226288170.HKD","IE0008369823.USD","HK0000165453.HKD","LU1813983027.USD","BK4588","LU1993786604.SGD","BK1515","01093","BK4585","LU1960683339.HKD","LU1328277881.USD","LU2039709279.SGD","LU0314109678.HKD","LU0067412154.USD","LU1226287792.SGD","IE00B031HY20.USD","SG9999004220.SGD","IE00BZ08YS42.EUR","VXUS","LU0072913022.USD","IE00BZ08YT58.USD","LU0326950275.SGD","LU1951186391.HKD","LU1152091754.HKD","IE00BZ08YR35.GBP","159646","KCAI","IE0008368742.USD","IE00B5MMRT66.SGD","LU1807302812.USD","BK1521","BK1191","IE00B543WZ88.USD","LU1152091168.USD","LU1226287875.USD","LU1226288253.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cspc.com.hk","stockEarnings":[{"period":"1week","weight":-0.1024},{"period":"1month","weight":-0.0062},{"period":"3month","weight":0.0244},{"period":"6month","weight":0.0052},{"period":"1year","weight":0.0405},{"period":"ytd","weight":0.0685}],"compareEarnings":[{"period":"1week","weight":0.0076},{"period":"1month","weight":-0.0242},{"period":"3month","weight":-0.0278},{"period":"6month","weight":-0.0706},{"period":"1year","weight":-0.0443},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CSPC Pharmaceutical Group Ltd is a company primarily engaged in the production and sales of pharmaceuticals. The Company's main businesses include finished drug manufacturing, bulk product business, functional food and other businesses. The Company's products mainly cover the nervous system, anti-tumor, anti-infective, cardiovascular, respiratory system, digestive and metabolic, and other therapeutic areas. The Company conducts its businesses in domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.53125,"avgChangeRate":0.009625},{"month":2,"riseRate":0.75,"avgChangeRate":0.094313},{"month":3,"riseRate":0.46875,"avgChangeRate":0.017543},{"month":4,"riseRate":0.59375,"avgChangeRate":0.057684},{"month":5,"riseRate":0.59375,"avgChangeRate":0.042479},{"month":6,"riseRate":0.3125,"avgChangeRate":0.001853},{"month":7,"riseRate":0.393939,"avgChangeRate":0.015989},{"month":8,"riseRate":0.454545,"avgChangeRate":0.011919},{"month":9,"riseRate":0.515152,"avgChangeRate":0.003046},{"month":10,"riseRate":0.545455,"avgChangeRate":0.005915},{"month":11,"riseRate":0.46875,"avgChangeRate":0.006831},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013329}],"exchange":"SEHK","name":"CSPC PHARMA","nameEN":"CSPC PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CSPC PHARMA(01093) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CSPC PHARMA,01093,CSPC PHARMA股票,CSPC PHARMA股票老虎,CSPC PHARMA股票老虎国际,CSPC PHARMA行情,CSPC PHARMA股票行情,CSPC PHARMA股价,CSPC PHARMA股市,CSPC PHARMA股票价格,CSPC PHARMA股票交易,CSPC PHARMA股票购买,CSPC PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CSPC PHARMA(01093),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CSPC PHARMA(01093) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}